Cytokines and hematopoietic stem cell mobilization.

Area of Science:

• Hematology
• Cell Biology
• Transplantation Immunology

Background:

• Hematopoietic stem cell transplantation (HSCT) is a standard treatment for hematologic malignancies and certain non-malignant disorders.
• Hematopoietic stem cells (HSCs) reside in the bone marrow and can be mobilized into peripheral blood for collection.
• Understanding HSC mobilization is crucial for optimizing HSCT outcomes.

Purpose of the Study:

• To review the fundamental biology of HSC mobilization.
• To elucidate the molecular mechanisms governing HSC homing and mobilization, with a focus on G-CSF induced mobilization.
• To discuss FDA-approved and investigational agents for enhancing HSC mobilization and transplantation.

Main Methods:

• Review of in vivo and clinical trial data on stem cell mobilization.
• Detailed examination of HSC microenvironmental interactions and key ligand-receptor pairs.
• Analysis of molecular players including chemokines, cytokines, and proteases.

Main Results:

• Key ligand-receptor interactions (e.g., CXCR4/SDF1, VLA4/VCAM1) are critical for HSC mobilization and homing.
• Granulocyte-colony stimulating factor (G-CSF) is a primary driver of HSC mobilization.
• Several agents are approved or in development to enhance HSC mobilization.

Conclusions:

• Enhanced understanding of HSC mobilization mechanisms can improve transplantation strategies.
• Targeting specific molecular pathways holds promise for optimizing HSC collection and engraftment.
• Further research into novel mobilization agents is essential for advancing HSCT.